Cargando…
Effect of dipeptidyl peptidase‐4 inhibitor on the progression of coronary artery disease evaluated by computed tomography in patients receiving insulin therapy for type 2 diabetes mellitus
BACKGROUND: We evaluated the effect of a dipeptidyl peptidase‐4 inhibitor (DPP‐4i) on the progression of obstructive coronary artery disease (OCAD) in patients with type 2 diabetes mellitus (T2DM) receiving insulin therapy. METHODS: Using a multicenter clinical data warehouse, we analyzed the patien...
Autores principales: | Choi, Young, Ko, Seung‐Hyun, Chang, Kiyuk, Yoo, Ki Dong, Ihm, Sang‐Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667629/ https://www.ncbi.nlm.nih.gov/pubmed/37528628 http://dx.doi.org/10.1111/1753-0407.13449 |
Ejemplares similares
-
Technical Recommendations for Computed Tomography Guidance of Intervention in the Right Ventricular Outflow Tract: Native RVOT, Conduits, and Bioprosthetic Valves
por: Han, B. Kelly, et al.
Publicado: (2023) -
Korean Society of Nephrology 2022 Recommendations on controversial issues in diagnosis and management of hyponatremia
por: Lee, Yeonhee, et al.
Publicado: (2022) -
Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease
por: Yang, Guang, et al.
Publicado: (2016) -
Effect of Dipeptidyl Peptidase-4 Inhibitors on Bone Health in Patients with Type 2 Diabetes Mellitus
por: Lee, Dong-Hwa, et al.
Publicado: (2021) -
Is type 2 diabetes mellitus a coronary heart disease equivalent or not? Do not just enjoy the debate and forget the patient!
por: Katsiki, Niki, et al.
Publicado: (2019)